Hemminki K - Search Results

1

Polymorphisms in the estrogen receptor beta gene and risk of breast cancer: no association.

Försti A, Zhao C, Israelsson E, Dahlman-Wright K, Gustafsson JA, Hemminki K. Försti A, et al. Among authors: hemminki k. Breast Cancer Res Treat. 2003 Jun;79(3):409-13. doi: 10.1023/a:1024020609833. Breast Cancer Res Treat. 2003. PMID: 12846425

2

DNA adducts in experimental cancer research.

Hemminki K, Försti A, Mustonen R, Savela K. Hemminki K, et al. J Cancer Res Clin Oncol. 1986;112(3):181-8. doi: 10.1007/BF00395910. J Cancer Res Clin Oncol. 1986. PMID: 3536940 Review.

3

Unique properties of cisplatin in reactions with nucleophiles.

Försti A, Hemminki K. Försti A, et al. Among authors: hemminki k. IARC Sci Publ. 1986;(78):101-10. IARC Sci Publ. 1986. PMID: 3583384 No abstract available.

4

32P-postlabelling analysis of DNA adducts in humans: adduct distribution and method improvement.

Szyfter K, Krüger J, Ericson P, Vaca C, Försti A, Hemminki K. Szyfter K, et al. Among authors: hemminki k. Mutat Res. 1994 Oct-Dec;313(2-3):269-76. doi: 10.1016/0165-1161(94)90056-6. Mutat Res. 1994. PMID: 7523911

5

32P-postlabelling method for the detection of 7-alkylguanine adducts formed by the reaction of different 1,2-alkyl epoxides with DNA.

Kumar R, Staffas J, Försti A, Hemminki K. Kumar R, et al. Among authors: hemminki k. Carcinogenesis. 1995 Mar;16(3):483-9. doi: 10.1093/carcin/16.3.483. Carcinogenesis. 1995. PMID: 7697802

6

Analysis of UV-induced DNA photoproducts by 32P-postlabelling.

Bykov VJ, Kumar R, Försti A, Hemminki K. Bykov VJ, et al. Among authors: hemminki k. Carcinogenesis. 1995 Jan;16(1):113-8. doi: 10.1093/carcin/16.1.113. Carcinogenesis. 1995. PMID: 7834795

7

Comparison of TLC- and HPLC-32P-postlabelling assay for cisplatin-DNA adducts.

Försti A, Staffas J, Hemminki K. Försti A, et al. Among authors: hemminki k. Carcinogenesis. 1994 Dec;15(12):2829-34. doi: 10.1093/carcin/15.12.2829. Carcinogenesis. 1994. PMID: 8001242

8

A 32P-postlabelling assay for DNA adducts induced by cis-diamminedichloroplatinum(II).

Försti A, Hemminki K. Försti A, et al. Among authors: hemminki k. Cancer Lett. 1994 Aug 15;83(1-2):129-37. doi: 10.1016/0304-3835(94)90309-3. Cancer Lett. 1994. PMID: 8062205

9

Testing of quantitative parameters in the 32P-postlabelling method.

Hemminki K, Försti A, Löfgren M, Segerbäck D, Vaca C, Vodicka P. Hemminki K, et al. IARC Sci Publ. 1993;(124):51-63. IARC Sci Publ. 1993. PMID: 8225510

10

Tamoxifen-induced DNA adducts in endometrial samples from breast cancer patients.

Hemminki K, Rajaniemi H, Lindahl B, Moberger B. Hemminki K, et al. Cancer Res. 1996 Oct 1;56(19):4374-7. Cancer Res. 1996. PMID: 8813128

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,460 results

Search Page

Filters